In the open-label phase 2 LITESPARK-003 study, led by Dana-Farber Cancer Institute's Toni Choueiri, MD, researchers ...

Genprex (GNPX) announced that the first patient has been enrolled and dosed in the Phase 2 expansion portion of the company’s Acclaim-3 ...

COVERING ORANGE COUNTY LIVE Nightlife in downtown Orlando is about to change again as the city adds more safety measures.Starting Friday, the City of Orlando will implement phase 2 of a public ...

WATERTOWN, Mass. - Vigil Neuroscience , Inc. (NASDAQ:VIGL), a clinical-stage biotechnology company, has announced the progression of its Alzheimer’s disease (AD) candidate, VG-3927, into a Phase 2 ...

(RTTNews) - Eni said it successfully started production of Phase 2 from the Baleine field. The company noted that the Final Investment Decision for the project was taken in December 2022 ...

We're nearing the end of Phase 5 of the MCU which marks the midway point of The Multiverse Saga, following the releases of Agatha All Along and Deadpool & Wolverine in 2024. This year sees the ...

No, it doesn't. There was an original China shock of the early 2000s and there is now a phase 2 China shock coming for certain very high-end manufacturing, which is strategically, symbolically and ...

PETALING JAYA: The Phase 2 rollout of Malaysia’s e-invoicing system on Jan 1 has presented challenges, with technical issues, unclear directives and logistical constraints complicating the ...

Patient enrollment is completed ahead of schedule for Contineum's Phase 2 clinical trial of PIPE-307, an oral remyelination ...

Rese-cel, previously called CABA-201, is a CAR T-cell therapy that's designed to treat MS by depleting B-cells.

Vigil Neuroscience has reported early clinical data on its Alzheimer’s disease candidate, positioning the biotech to advance its small molecule in the footsteps of AbbVie and Alector’s failed rival ...

Vigil Neuroscience reported a strong safety profile and 50% sTREM2 reduction in an early-stage trial for VG-3927, potentially ...